Seeing Is Believing
Currently out of the existing stock ratings of Shannon O'callaghan, 2 are a SELL (3.33%), 12 are a HOLD (20%), 46 are a BUY (76.67%).
Analyst Shannon O'callaghan, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 89.26% that have a potential upside of 44.94% achieved within 892 days.
Shannon O'callaghan’s has documented 137 price targets and ratings displayed on 15 stocks. The coverage is on Industrials, Healthcare, Technology sectors.
Most recent stock forecast was given on GH, Guardant Health at 05-Mar-2025.
Analyst best performing recommendations are on SPXC (SPX CORP).
The best stock recommendation documented was for DHR (DANAHER) at 5/10/2016. The price target of $72.59 was fulfilled within 290 days with a profit of $32.06 (79.1%) receiving and performance score of 2.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$295
$3.51 (1.20%)
$200
2 months 21 days ago
(22-Jul-2025)
40/40 (100%)
$32.14 (12.23%)
984
Buy
$321
$29.51 (10.12%)
$216
2 months 26 days ago
(17-Jul-2025)
4/5 (80%)
$58.05 (22.08%)
177
Buy
$260
$-31.49 (-10.80%)
$190
4 months 29 days ago
(14-May-2025)
6/6 (100%)
$31.23 (13.65%)
165
Buy
$222
$-69.49 (-23.84%)
$212
5 months 20 days ago
(23-Apr-2025)
11/11 (100%)
$25.12 (12.76%)
134
Buy
$200
$-91.49 (-31.39%)
$155
6 months 4 days ago
(09-Apr-2025)
13/13 (100%)
$18.98 (10.49%)
1179
What Year was the first public recommendation made by Shannon O'callaghan?